Informations: Ceci n’est pas la version la plus récente du modèle de données. Vous trouverez un aperçu de la version à gauche, sous Versions. Vous trouverez la version la plus actuelle ici.
Informations:
Erreur:
ID
34478
Description
A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01615406
Lien
https://clinicaltrials.gov/show/NCT01615406
Mots-clés
Versions (3)
- 17/01/2019 17/01/2019 -
- 22/05/2019 22/05/2019 -
- 23/05/2019 23/05/2019 - Sarah Riepenhausen
Détendeur de droits
see on clinicaltrials.gov
Téléchargé le
17 janvier 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Prostate Cancer NCT01615406
Eligibility Prostate Cancer NCT01615406
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT01615406
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
ID.1
Item
male aged 21 years or older.
boolean
ID.2
Item
ability to provide signed informed consent and willingness to comply with protocol requirements.
boolean
ID.3
Item
past biopsy indicating the presence of adenocarcinoma of the prostate gland.
boolean
ID.4
Item
participant is deemed to have tissue suspicious of prostate cancer involvement that is amenable to biopsy/resection.
boolean
ID.5
Item
have had, or will undergo diagnostic ct or mri imaging prior to surgery.
boolean
ID.6
Item
participants must agree to use an acceptable form of birth control throughout the study period. participants must use condoms for a period of seven days after study drug administration, if engaged in sexual activity.
boolean
ID.7
Item
participants for whom participating would significantly delay the scheduled standard of care therapy.
boolean
ID.8
Item
participants administered a radioisotope within 5 physical half lives prior to study enrollment.
boolean
ID.9
Item
participants with any medical condition or other circumstances that, in the opinion of the investigator, would significantly decrease obtaining reliable data, achieving study objectives or completing the study.
boolean